Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults
Clinical trial NCT00528489 · COMPLETED
Trial details
- NCT number
- NCT00528489
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2010-01-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.